Literature DB >> 25976411

Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.

Karla L Otterpohl1, Karen A Gould.   

Abstract

Germline mutations in the adenomatous polyposis coli (APC) gene cause familial adenomatous polyposis (FAP), a hereditary colon cancer syndrome in which affected individuals may develop 100-1000s of colonic adenomas. In families affected by FAP, adenoma number can vary markedly between individuals, despite the fact that these individuals carry the same APC mutation. In at least some FAP pedigrees, evidence suggests that these phenotypic differences are caused by segregating modifier alleles that impact adenoma number. However, identifying these modifiers in the human population is difficult, therefore mouse models are essential. Using the Apc (Min/+) mouse colon cancer model, we previously mapped one such modifier, Mom5, to a 25 Mbp region of chromosome 5 that contains hundreds of genes. The purpose of the present study was to refine the Mom5 interval and evaluate candidate genes for the Mom5 modifier of intestinal neoplasia. Recombinant mice were used to narrow the Mom5 interval to 8.1 Mbp containing 70 genes. In silico and gene expression analyses were utilized to identify and evaluate potential candidate genes that reside within this interval. These analyses identified seven genes within the Mom5 interval that contain variants between the B6 and 129P2 strains. These genes represent the most likely candidates for the Mom5 modifier.

Entities:  

Mesh:

Year:  2015        PMID: 25976411     DOI: 10.1007/s00335-015-9567-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  49 in total

Review 1.  Low penetrance genes associated with increased risk for breast cancer.

Authors:  B L Weber; K L Nathanson
Journal:  Eur J Cancer       Date:  2000-06       Impact factor: 9.162

2.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9.

Authors:  P Rozen; Z Samuel; R Shomrat; C Legum
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

4.  Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes.

Authors:  M D Crabtree; I P M Tomlinson; S V Hodgson; K Neale; R K S Phillips; R S Houlston
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

5.  Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation.

Authors:  F M Giardiello; A J Krush; G M Petersen; S V Booker; M Kerr; L L Tong; S R Hamilton
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

6.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors:  M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 7.  Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene.

Authors:  Koji Aoki; Makoto M Taketo
Journal:  J Cell Sci       Date:  2007-10-01       Impact factor: 5.285

Review 8.  CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

9.  Novel germline APC gene mutation in a large familial adenomatous polyposis kindred displaying variable phenotypes.

Authors:  R J Scott; R van der Luijt; M Spycher; J L Mary; A Müller; T Hoppeler; M Haner; H Müller; S Martinoli; P L Brazzola
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.

Authors:  Manuel Koch; Fadi Hussein; Andreas Woeste; Carsten Gründker; Karl Frontzek; Günter Emons; Thomas Hawighorst
Journal:  Breast Cancer Res Treat       Date:  2010-08-17       Impact factor: 4.872

View more
  4 in total

1.  Somatic recombination in adult tissues: What is there to learn?

Authors:  Katarzyna Siudeja; Allison J Bardin
Journal:  Fly (Austin)       Date:  2016-11-11       Impact factor: 2.160

2.  Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk.

Authors:  Karla L Otterpohl; Karen A Gould
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

Review 3.  The genetic basis of colonic adenomatous polyposis syndromes.

Authors:  Bente A Talseth-Palmer
Journal:  Hered Cancer Clin Pract       Date:  2017-03-16       Impact factor: 2.857

4.  CD36 - a plausible modifier of disease phenotype in familial adenomatous polyposis.

Authors:  Merran Holmes; Toni Connor; Christopher Oldmeadow; Peter G Pockney; Rodney J Scott; Bente A Talseth-Palmer
Journal:  Hered Cancer Clin Pract       Date:  2018-07-28       Impact factor: 2.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.